Marico Industries

Marico buys Derma Rx's aesthetic skin care business in Singapore to expand Kaya

25 May 2010

Marico buys Colgate Palmolive's Malaysian business

04 Jan 2010

Starcom IP wins digital marketing mandate for Kaya

05 Aug 2009

Marico profits rise 8.9 per cent; Sundari stake to divested to Wellness Systems

23 Apr 2009

Marico assigns Sweekar and Revive to Rediffusion Y&R

26 Mar 2009

Marico selects BBH as creative partner

25 Mar 2009

Marico to end marketing Nissin's Top Ramen brand

24 Mar 2008

Marico sells 'Sil' to Denmark's Good Food Group

12 Mar 2008

Marico signs on Sreesanth as brand ambassador No. 2

22 Dec 2007

Marico goes the oily way: HLL prefers conditioners

04 Feb 2006

View details about the software product Informachine News Trackers

Latest articles

Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

 Sigma Advanced to acquire UK aerospace supplier Bromford for ₹153 crore

Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

 Akasa Air plans ₹1,050 crore fundraising to support growth amid higher costs

AI startup Reflection signs over $1 billion computing deal with Nebius

 AI startup Reflection signs over $1 billion computing deal with Nebius

Tata Power explores $450 million overseas loan for business operations

 Tata Power explores $450 million overseas loan for business operations

TCS wins technology contract for New York JFK Airport’s $19 billion terminal

 TCS wins technology contract for New York JFK Airport’s $19 billion terminal

South Korean firms unveil $195 billion investment in AI and advanced industries

 South Korean firms unveil $195 billion investment in AI and advanced industries

HCLTech wins $1.14 billion AI transformation deal with European client

 HCLTech wins $1.14 billion AI transformation deal with European client

Microsoft launches Frontier to help enterprises accelerate AI adoption

 Microsoft launches Frontier to help enterprises accelerate AI adoption

AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs

 AstraZeneca signs up to $1.77 billion CSPC deal for kidney disease drugs